BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 31336983)

  • 41. Small molecule integrin antagonists in cancer therapy.
    Paolillo M; Russo MA; Serra M; Colombo L; Schinelli S
    Mini Rev Med Chem; 2009 Oct; 9(12):1439-46. PubMed ID: 19929817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A.
    Pelillo C; Mollica H; Eble JA; Grosche J; Herzog L; Codan B; Sava G; Bergamo A
    J Inorg Biochem; 2016 Jul; 160():225-35. PubMed ID: 26961176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.
    Sheldrake HM; Patterson LH
    J Med Chem; 2014 Aug; 57(15):6301-15. PubMed ID: 24568695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin.
    Milner R
    Glia; 2009 May; 57(7):714-23. PubMed ID: 18985734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection.
    Veettil MV; Sadagopan S; Sharma-Walia N; Wang FZ; Raghu H; Varga L; Chandran B
    J Virol; 2008 Dec; 82(24):12126-44. PubMed ID: 18829766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrin function and signaling as pharmacological targets in cardiovascular diseases and in cancer.
    Paulhe F; Manenti S; Ysebaert L; Betous R; Sultan P; Racaud-Sultan C
    Curr Pharm Des; 2005; 11(16):2119-34. PubMed ID: 15974963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions.
    Tantivejkul K; Vucenik I; Shamsuddin AM
    Anticancer Res; 2003; 23(5A):3681-9. PubMed ID: 14666664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiation-induced modifications of the tumor microenvironment promote metastasis.
    Rüegg C; Monnier Y; Kuonen F; Imaizumi N
    Bull Cancer; 2011 Jun; 98(6):47-57. PubMed ID: 21636344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model.
    Gvozdenovic A; Boro A; Meier D; Bode-Lesniewska B; Born W; Muff R; Fuchs B
    Oncotarget; 2016 Aug; 7(34):55141-55154. PubMed ID: 27409827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Orphan nuclear receptor TR3/Nur77 differentially regulates the expression of integrins in angiogenesis.
    Ye T; Peng J; Liu X; Hou S; Niu G; Li Y; Zeng H; Zhao D
    Microvasc Res; 2019 Mar; 122():22-33. PubMed ID: 30391133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles for GP IIb/IIIa and αvβ3 integrins in MDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction.
    Zhao F; Li L; Guan L; Yang H; Wu C; Liu Y
    Cancer Lett; 2014 Mar; 344(1):62-73. PubMed ID: 24176823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. alphavbeta5/beta6 integrin suppression leads to a stimulation of alpha2beta1 dependent cell migration resistant to PI3K/Akt inhibition.
    Defilles C; Lissitzky JC; Montero MP; André F; Prévot C; Delamarre E; Marrakchi N; Luis J; Rigot V
    Exp Cell Res; 2009 Jul; 315(11):1840-9. PubMed ID: 19328197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.
    Villegas-Pineda JC; Garibay-Cerdenares OL; Hernández-Ramírez VI; Gallardo-Rincón D; Cantú de León D; Pérez-Montiel-Gómez MD; Talamás-Rohana P
    Pathol Res Pract; 2015 Dec; 211(12):973-81. PubMed ID: 26549463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heparanase in Cancer Metastasis - Heparin as a Potential Inhibitor of Cell Adhesion Molecules.
    Bendas G; Borsig L
    Adv Exp Med Biol; 2020; 1221():309-329. PubMed ID: 32274715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrins and Exosomes, a Dangerous Liaison in Cancer Progression.
    Paolillo M; Schinelli S
    Cancers (Basel); 2017 Jul; 9(8):. PubMed ID: 28933725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer.
    Aksorn N; Chanvorachote P
    Anticancer Res; 2019 Feb; 39(2):541-548. PubMed ID: 30711928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?
    Lavergne M; Janus-Bell E; Schaff M; Gachet C; Mangin PH
    Cancers (Basel); 2017 Sep; 9(10):. PubMed ID: 28956830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. αv-Integrin isoform expression in primary human tumors and brain metastases.
    Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
    Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion.
    Duperret EK; Dahal A; Ridky TW
    J Cell Sci; 2015 Nov; 128(21):3997-4013. PubMed ID: 26359297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.
    Monferran S; Skuli N; Delmas C; Favre G; Bonnet J; Cohen-Jonathan-Moyal E; Toulas C
    Int J Cancer; 2008 Jul; 123(2):357-364. PubMed ID: 18464290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.